Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
Oliver Damm(Bielefeld University), Wolfgang Greiner(Bielefeld University), Markus A. Rose(Goethe University Frankfurt), Markus Knuf(Helios Kliniken), Martin Eichner(University Hospital Cologne), H. Krüger(Pfizer (Germany)), Peter Wutzler(Jena University Hospital), Johannes G. Liese(Universitätsklinikum Würzburg)
Cited by 37
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465